Stephen V Frye
Affiliations: | UNC Eshelman School of Pharmacy | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
Drug DiscoveryWebsite:
https://pharmacy.unc.edu/news/directory/svfrye/Google:
"Stephen Vernon Frye"Bio:
http://studylib.net/doc/8143236/stephen-v.-frye---unc-lineberger-comprehensive-cancer-center
https://books.google.com/books?id=feautgAACAAJ
Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Ernest Ludwig Eliel | grad student | 1983-1987 | UNC Chapel Hill | |
| (Stereoselective Syntheses Based on Chiral 1,3-oxathianes: Synthesis of Mevalolactone and Citramalic Acid and Investigation of the Mechanism of Diastereoselection.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Cui G, Botuyan MV, Drané P, et al. (2023) An autoinhibited state of 53BP1 revealed by small molecule antagonists and protein engineering. Nature Communications. 14: 6091 |
| Cui G, Botuyan MV, Drané P, et al. (2023) An autoinhibited state of 53BP1 revealed by chemical probes and protein engineering. Biorxiv : the Preprint Server For Biology |
| Suh JL, Bsteh D, Hart B, et al. (2021) Reprogramming CBX8-PRC1 function with a positive allosteric modulator. Cell Chemical Biology |
| Puhl AC, Bogart JW, Haberman VA, et al. (2020) Discovery and Characterization of Peptide Inhibitors for CIB1. Acs Chemical Biology |
| Rectenwald JM, Guduru SKR, Dang Z, et al. (2020) Design and Construction of a Focused DNA-Encoded Library for Multivalent Chromatin Reader Proteins. Molecules (Basel, Switzerland). 25 |
| Barnes DE, Wang X, Frye SV, et al. (2020) Abstract 6388: MERTK and ROCK inhibitors mediate synergistic AML cell death and enhance therapeutic activity in combination with cytotoxic chemotherapy Cancer Research. 80: 6388-6388 |
| Yan D, Huelse J, Parker R, et al. (2020) Abstract 1882: MERTK drives residual tumor growth in EGFR-mutated non-small cell lung cancer cells treated with osimertinib Cancer Research. 80: 1882-1882 |
| Maffuid KA, Torrice CD, Hardy B, et al. (2020) Abstract 1743: Evaluation of the effects of combined chemical inhibition of PARP and BET proteins in preclinical models of urothelial bladder cancer Cancer Research. 80: 1743-1743 |
| Foley CA, Potjewyd F, Lamb KN, et al. (2019) Assessing the Cell Permeability of Bivalent Chemical Degraders Using the Chloroalkane Penetration Assay. Acs Chemical Biology |
| Da C, Zhang D, Stashko M, et al. (2019) Data-driven construction of anti-tumor agents with controlled polypharmacology. Journal of the American Chemical Society |